Your browser doesn't support javascript.
loading
Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756).
Calleris, Giorgio; Rouprêt, Morgan; Seisen, Thomas; Bendjeddou, Lyamin; Chevallier, Thierry; Masson-Lecomte, Alexandra; Thibault, Constance; Neuzillet, Yann; Audenet, François; Xylinas, Evanguelos; Houédé, Nadine.
Afiliación
  • Calleris G; GRC 5 Predictive Onco-Urology Research Group and Urology Department, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University, 75013, Paris, France.
  • Rouprêt M; Department of Surgical Sciences, Urology, University of Turin, Turin, Italy.
  • Seisen T; GRC 5 Predictive Onco-Urology Research Group and Urology Department, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University, 75013, Paris, France. mroupret@gmail.com.
  • Bendjeddou L; GRC 5 Predictive Onco-Urology Research Group and Urology Department, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University, 75013, Paris, France.
  • Chevallier T; Research and Innovation Department, Nimes University Hospital, 30029, Nimes, France.
  • Masson-Lecomte A; Department of Biostatistics, Epidemiology, Public Health and Innovation in Methodology (BESPIM), Nimes University Hospital, 30029, Nimes, France.
  • Thibault C; UMR 1302, Institute Desbrest of Epidemiology and Public Health, INSERM, Univ. Montpellier, Montpellier, France.
  • Neuzillet Y; Department of Urology, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité University, 75010, Paris, France.
  • Audenet F; Department of Medical Oncology, Assistance Publique-Hôpitaux de Paris, Hopital Européen Georges Pompidou, Paris, France.
  • Xylinas E; Department of Urology, Foch Hospital, Paris Saclay University, Suresnes, France.
  • Houédé N; Department of Urology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
World J Urol ; 41(12): 3413-3420, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37698632
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ureterales / Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Renales Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: World J Urol Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ureterales / Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Renales Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: World J Urol Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Alemania